Jasper Therapeutics, Inc. (JSPRW) › Operating IncomeJasper Therapeutics, Inc. (JSPRW) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: $2.90M2020: -$20.68M2021: -$36.83M2022: -$51.20M2023: -$68.86M2024: -$76.24M2025: -$83.88M-$83.88M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$83.88M-10.0%2024-$76.24M-10.7%2023-$68.86M-34.5%2022-$51.20M-39.0%2021-$36.83M-78.1%2020-$20.68M-813.2%2019$2.90M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share